Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven ...

Earlier in December 2025, Recursion Pharmaceuticals reported positive Phase 1b/2 TUPELO trial data for REC-4881 in familial adenomatous polyposis, showing rapid and durable reductions in polyp burden ...

RXRX Stock jumps after JPMorgan upgrade and trial data boost, fueling investor optimism in Recursion’s AI drug discovery ...

The simulation hypothesis—the idea that our universe might be an artificial construct running on some advanced alien computer ...

In 2025, Anthropic will grow from $1 billion to $9 billion in ARR (annual recurring revenue). OpenAI, meanwhile, will go from ...

Since the 2000s, Google Search—and later YouTube and Discover—served as the primary discovery and monetization engines for ...

Three recent graduates from the MSU photo program noticed a glaring gap in the photo-journal world. While there has been ...

Former Google CEO Eric Schmidt expressed astonishment at AI's rapid progress, particularly its ability to autonomously generate code, admitting his ow ...

Getting good at LeetCode Java isn’t just about solving problems; it’s about having a good plan. You need to know where to ...

Skills—a capability that allows users to teach Claude repeatable workflows—was introduced in October, and now Anthropic is ...